Senior insider sale
Exec. VP and CLO at PTC THERAPEUTICS, INC. — senior position signals high conviction
$841.5K
11.64K shares
What this filing means
BOULDING MARK ELLIOTT plans to sell 11.64K shares of PTC THERAPEUTICS, INC. valued at approximately $841.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/8/2026ACC: 0001959173-26-003439
Officer· Exec. VP and CLO
Since Jan 2019
11.64K
Shares to sell
$841.5K
Approx. market value
3.54K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Option Granted - 01/03/2025
Cash
5/8/2026
3.54KTotal acquired3.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/8/2026 | Option Granted - 01/03/2025 Cash | 3.54K | — |
| Total | 3.54K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.27K
Market value
$157.3K
4/6/2026
—Completed
Units to sell
3.02K
Market value
$209.8K
2/19/2026
—Completed
Units to sell
2.81K
Market value
$194.9K
2/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.54K
Market value
$279.6K
5/8/2026
Total
Units
11.64K
Value
$841.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/6/2026 | 2.27K | $157.3K | — | Completed |
2/19/2026 | 3.02K | $209.8K | — | Completed |
2/17/2026 | 2.81K | $194.9K | — | Completed |
| Planned — Approximate Date | ||||
5/8/2026 | 3.54K | $279.6K | NASDAQ | Planned |
| Total | 11.64K | $841.5K | ||